Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XHR
1101
Xenia Hotels & Resorts
XHR
$1.82B
| $10.5M | 0.02% |
607,800
-650,897
| -52% | -$13.2M |
|
1102
Dycom Industries
DY
$10.6B
| $10.4M | 0.02% |
193,301
+188,006
| +3,551% | +$12.6M |
|
1103
New Jersey Resources
NJR
$5.46B
| $10.4M | 0.02% |
228,352
+12,518
| +6% | +$590K |
|
|
GNBC
1104
DELISTED
Green Bancorp, Inc
GNBC
| $10.4M | 0.02% |
+605,604
| New | +$11.7M |
|
1105
CALL
Bunge Global
BG
$21.5B
| $10.4M | 0.02% |
194,200
+95,200
| +96% | +$5.88M |
|
|
INVX
1106
Innovex International
INVX
$2.01B
| $10.4M | 0.02% |
345,534
+242,402
| +235% | +$9.78M |
|
1107
CALL
Xerox
XRX
$387M
| $10.4M | 0.02% |
525,000
+262,500
| +100% | +$6.74M |
|
|
TGNA
1108
DELISTED
TEGNA Inc
TGNA
| $10.3M | 0.02% |
948,397
+813,469
| +603% | +$9.82M |
|
|
RHT
1109
CALL
DELISTED
Red Hat Inc
RHT
| $10.3M | 0.02% |
+58,600
| New | +$9.29M |
|
|
RHT
1110
PUT
DELISTED
Red Hat Inc
RHT
| $10.3M | 0.02% |
+58,500
| New | +$9.27M |
|
1111
H.B. Fuller
FUL
$3.07B
| $10.3M | 0.02% |
+240,435
| New | +$10.9M |
|
1112
Myriad Genetics
MYGN
$305M
| $10.2M | 0.02% |
351,688
-615,547
| -64% | -$22.1M |
|
|
PRO
1113
DELISTED
PROS Holdings
PRO
| $10.2M | 0.02% |
325,421
-15,328
| -4% | -$485K |
|
|
TMQ
1114
Trilogy Metals
TMQ
$663M
| $10.2M | 0.02% |
5,895,943
+550,883
| +10% | +$1.12M |
|
|
CPE
1115
DELISTED
Callon Petroleum Company
CPE
| $10.2M | 0.02% |
156,597
-19,241
| -11% | -$1.86M |
|
|
CHCT
1116
Community Healthcare Trust
CHCT
$430M
| $10.2M | 0.02% |
352,314
+62,504
| +22% | +$1.86M |
|
1117
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
| $10.2M | 0.02% |
92,064
+45,701
| +99% | +$5.04M |
|
1118
Sixth Street Specialty
TSLX
$1.81B
| $10.2M | 0.02% |
561,095
+327,542
| +140% | +$6.5M |
|
1119
Ternium
TX
$10.8B
| $10.1M | 0.02% |
374,004
-169,008
| -31% | -$5.04M |
|
1120
Amdocs
DOX
$6.51B
| $10.1M | 0.02% |
+172,775
| New | +$10.8M |
|
1121
HealthEquity
HQY
$8.81B
| $10.1M | 0.02% |
169,418
+165,008
| +3,742% | +$13.3M |
|
1122
Idacorp
IDA
$7.96B
| $10.1M | 0.02% |
108,419
+18,183
| +20% | +$1.78M |
|
1123
Wynn Resorts
WYNN
$10.2B
| $10.1M | 0.02% |
101,760
-34,108
| -25% | -$3.68M |
|
|
GLOG
1124
DELISTED
GASLOG LTD
GLOG
| $10M | 0.02% |
608,962
+472,363
| +346% | +$9.42M |
|
|
INST
1125
DELISTED
Instructure, Inc.
INST
| $10M | 0.02% |
266,739
+91,009
| +52% | +$3.21M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.